February 16, 2016
Stewart JJ et al. Cytometry B Clin Cytom 2016;90(2):110-6.
Role of Receptor Occupancy Assays by Flow Cytometry in Drug Development
You might also be interested by
CellTalk Blog
How to Select the Optimal TBNK Panel: Matching Immune Monitoring to Clinical Context
November 25, 2025
Immune Monitoring
More infoCellTalk Blog
ELISpot vs. ICS: Optimizing Immune Monitoring in Clinical Trials with the Right Functional Assay
November 19, 2024
Immune Monitoring
More infoCellTalk Blog
Measure Target Engagement With Receptor Occupancy Assays by Flow Cytometry
September 17, 2024
Immune Monitoring
More infoBrochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More info